Opinion

Video

Moving Beyond the Joint: Unraveling Gout's Systemic and Renal Implications

Key opinion leaders analyze EULAR 2024 updates on gout, chronic inflammation's systemic impact, and gout-chronic kidney disease (CKD) connections, while examining urate-lowering therapies for gout management, particularly in patients with CKD.

To watch the video series component of this episode, click here

Related Videos
Duloxetine for Patients with COPD Suffering from Comorbid Depression
Enhancing Standards for Ethical Responsibilities within Clinical Research
Jennifer Flemming, MD | Credit: AASLD
Related Content
Kidneys | Credit: Fotolia
January 20th 2025

Study Describes Clinical Features, Prognosis of Patients with IgAN, Nephrotic Syndrome

Abigail Brooks, MA
Default thumbnail for The Medical Sisterhood podcast
January 16th 2025

Medical Sisterhood: Polished and Powerful—Women Leading the Charge in Advocacy

Mona Shahriari, MD, FAAD Shadi Kourosh, MD, MPH
FDA Accepts Plozasiran NDA for Familial Chylomicronemia Syndrome | Image Credit: US Food and Drug Administration
January 20th 2025

FDA Accepts Plozasiran NDA for Familial Chylomicronemia Syndrome

Connor Iapoce
Diabetes Dialogue: ADA’s 2025 Standards of Care in Diabetes | Image Credit: HCPLive
January 16th 2025

Diabetes Dialogue: ADA’s 2025 Standards of Care in Diabetes Technology

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
Joselyn Rojas-Quintero, MSc, MD | Credit: American Lung Association
January 20th 2025

Metabolic Reprograming in Alveolar Epithelial Cells Type 2: Repurposing Old Drugs for Emphysema Treatment

Joselyn Rojas-Quintero, MD
Abebaw Yohannes, MSc, PhD | Credit: American Lung Association
January 20th 2025

Exploring Duloxetine for Depression in COPD: A Pilot Study

Abebaw Yohannes, MSc, PhD
© 2025 MJH Life Sciences

All rights reserved.